25
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mini G protein probes for active G protein–coupled receptors (GPCRs) in live cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          G protein–coupled receptors (GPCRs) are key signaling proteins that regulate nearly every aspect of cell function. Studies of GPCRs have benefited greatly from the development of molecular tools to monitor receptor activation and downstream signaling. Here, we show that mini G proteins are robust probes that can be used in a variety of assay formats to report GPCR activity in living cells. Mini G (mG) proteins are engineered GTPase domains of Gα subunits that were developed for structural studies of active-state GPCRs. Confocal imaging revealed that mG proteins fused to fluorescent proteins were located diffusely in the cytoplasm and translocated to sites of receptor activation at the cell surface and at intracellular organelles. Bioluminescence resonance energy transfer (BRET) assays with mG proteins fused to either a fluorescent protein or luciferase reported agonist, superagonist, and inverse agonist activities. Variants of mG proteins (mGs, mGsi, mGsq, and mG12) corresponding to the four families of Gα subunits displayed appropriate coupling to their cognate GPCRs, allowing quantitative profiling of subtype-specific coupling to individual receptors. BRET between luciferase–mG fusion proteins and fluorescent markers indicated the presence of active GPCRs at the plasma membrane, Golgi apparatus, and endosomes. Complementation assays with fragments of NanoLuc luciferase fused to GPCRs and mG proteins reported constitutive receptor activity and agonist-induced activation with up to 20-fold increases in luminescence. We conclude that mG proteins are versatile tools for studying GPCR activation and coupling specificity in cells and should be useful for discovering and characterizing G protein subtype–biased ligands.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: not found

          NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells.

          Protein-fragment complementation assays (PCAs) are widely used for investigating protein interactions. However, the fragments used are structurally compromised and have not been optimized nor thoroughly characterized for accurately assessing these interactions. We took advantage of the small size and bright luminescence of NanoLuc to engineer a new complementation reporter (NanoBiT). By design, the NanoBiT subunits (i.e., 1.3 kDa peptide, 18 kDa polypeptide) weakly associate so that their assembly into a luminescent complex is dictated by the interaction characteristics of the target proteins onto which they are appended. To ascertain their general suitability for measuring interaction affinities and kinetics, we determined that their intrinsic affinity (KD = 190 μM) and association constants (kon = 500 M(-1) s(-1), koff = 0.2 s(-1)) are outside of the ranges typical for protein interactions. The accuracy of NanoBiT was verified under defined biochemical conditions using the previously characterized interaction between SME-1 β-lactamase and a set of inhibitor binding proteins. In cells, NanoBiT fusions to FRB/FKBP produced luminescence consistent with the linear characteristics of NanoLuc. Response dynamics, evaluated using both protein kinase A and β-arrestin-2, were rapid, reversible, and robust to temperature (21-37 °C). Finally, NanoBiT provided a means to measure pharmacology of kinase inhibitors known to induce the interaction between BRAF and CRAF. Our results demonstrate that the intrinsic properties of NanoBiT allow accurate representation of protein interactions and that the reporter responds reliably and dynamically in cells.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            PRESTO-TANGO: an open-source resource for interrogation of the druggable human GPCR-ome

            G protein-coupled receptors (GPCRs) are essential mediators of cellular signaling and important targets of drug action. Of the approximately 350 non-olfactory human GPCRs, more than 100 are still considered “orphans” as their endogenous ligand(s) remain unknown. Here, we describe a unique open-source resource that provides the capacity to interrogate the druggable human GPCR-ome via a G protein-independent β-arrestin recruitment assay. We validate this unique platform at more than 120 non-orphan human GPCR targets, demonstrate its utility for discovering new ligands for orphan human GPCRs, and describe a method (PRESTO-TANGO; Parallel Receptor-ome Expression and Screening via Transcriptional Output - TANGO) for the simultaneous and parallel interrogation of the entire human GPCR-ome.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Seven-transmembrane receptors.

              Seven-transmembrane receptors, which constitute the largest, most ubiquitous and most versatile family of membrane receptors, are also the most common target of therapeutic drugs. Recent findings indicate that the classical models of G-protein coupling and activation of second-messenger-generating enzymes do not fully explain their remarkably diverse biological actions.
                Bookmark

                Author and article information

                Journal
                J Biol Chem
                J. Biol. Chem
                jbc
                jbc
                JBC
                The Journal of Biological Chemistry
                American Society for Biochemistry and Molecular Biology (11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A. )
                0021-9258
                1083-351X
                11 May 2018
                9 March 2018
                9 March 2018
                : 293
                : 19
                : 7466-7473
                Affiliations
                From the []Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, Georgia 30912,
                the [§ ]Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi 980-8578 Japan, and
                the []MRC Laboratory of Molecular Biology, Cambridge CB20QH, United Kingdom
                Author notes
                [4 ] To whom correspondence should be addressed: Dept. of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA 30912-2300. Tel.: 706-721-6336; Fax: 706-721-2345; E-mail: nelambert@ 123456augusta.edu .
                [1]

                Supported by Japan Science and Technology Agency (JST) Grant JPMJPR1331 and Japan Agency for Medical Research and Development (AMED) Grant JP17gm5910013.

                [2]

                Present address: Creoptix AG, Einsiedlerstrasse 34, CH-8820 Wädenswil, Switzerland.

                [3]

                Present address: Warwick Integrative Synthetic Biology Centre, University of Warwick, Coventry CV4 7AL, United Kingdom.

                Edited by Henrik G. Dohlman

                Article
                RA118.001975
                10.1074/jbc.RA118.001975
                5949987
                29523687
                35640d6c-6e0b-4cc8-b081-96b149e4808e
                © 2018 Wan et al.

                Published under exclusive license by The American Society for Biochemistry and Molecular Biology, Inc.

                Author's Choice—Final version free via Creative Commons CC-BY license.

                History
                : 18 January 2018
                : 2 March 2018
                Funding
                Funded by: HHS | National Institutes of Health (NIH) , open-funder-registry 10.13039/100000002;
                Award ID: GM078319
                Award ID: GM109879
                Funded by: RCUK | Medical Research Council (MRC) , open-funder-registry 10.13039/501100000265;
                Award ID: MC_U105197215
                Funded by: EC | FP7 | FP7 Ideas: European Research Council (FP7 Ideas) , open-funder-registry 10.13039/100011199;
                Award ID: EMPSI 339995
                Funded by: MEXT | Japan Science and Technology Agency (JST) , open-funder-registry 10.13039/501100002241;
                Award ID: JPMJPR1331
                Funded by: Japan Agency for Medical Research and Development (AMED) , open-funder-registry 10.13039/100009619;
                Award ID: JP17gm5910013
                Categories
                Editors' Picks

                Biochemistry
                g protein–coupled receptor (gpcr),g protein,arrestin,biosensor,molecular pharmacology,bret,mini g protein,nanoluc,protein complementation

                Comments

                Comment on this article